IPO Do Overs Are Do...
Open Question
Hello Dan.
DNDN is slipping down. On something this gappy, is it better to wait until it
has a price range of pick it up close to its opening (gapped up) price?
Thanks.
Page 1 of 1
Thank you for the lesson.
Rate Now:
Average Rating: 0.00 / 0
Whew. I sure wouldn't be buying a stock that's gapped up over 150%. What's to
buy? Where's the catalyst going forward? This is the perfect time to be
selling.
I'm not talking from a forward-looking standpoint. The only relevant metric for
biotech in my book is cash burn rate. It is a very difficult sector to
understand. But from a risk management point of view, the upside is limited
versus a very big downside.
Rate Now:
Average Rating: 0.00 / 0
Page 1 of 1
